Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of therapeutics and diagnostics that improve patient outcomes. Our extensive portfolio of normal and diseased human biospecimens, cellular starting materials, and preclinical ADME-tox products and services accelerates research with high-quality, highly characterized materials, complemented by expertise in cell biology. Our comprehensive suite of lab services, including molecular pathology, genomics, proteomics, and flow cytometry, delivers critical data and insights for biomarker discovery across the full spectrum of retrospective and prospective clinical trials, from assay development and validation through Phase 3 and post-approval pathologist training. With a vision to be the most trusted partner in life science research and clinical development, Discovery Life Sciences is committed to advancing scientific research and transforming lives. Visit www.dls.com to learn more
Looking for a particular Discovery Life Sciences employee's phone or email?
The Discovery Life Sciences annual revenue was $31.1 million in 2026.
Greg Herrema is the CEO of Discovery Life Sciences.
439 people are employed at Discovery Life Sciences.
Discovery Life Sciences is based in Huntsville, Alabama.
The NAICS codes for Discovery Life Sciences are [3254, 325, 32].
The SIC codes for Discovery Life Sciences are [283, 28].